<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:DOC-PI46IBZ3/ae00425c-1792-456b-9b01-419ddf2cc51f/PDF"><dcterms:extent>88 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:DOC-PI46IBZ3/0f19f17b-1573-4f62-9690-5439d34dedb1/TEXT"><dcterms:extent>34 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1994-2025"><edm:begin xml:lang="en">1994</edm:begin><edm:end xml:lang="en">2025</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:DOC-PI46IBZ3"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:spr-46R7GGHL" /><dcterms:issued>1998</dcterms:issued><dc:creator>Bratanič, Borut</dc:creator><dc:creator>Groleger, Katja</dc:creator><dc:creator>Veličković Perat, Milivoj</dc:creator><dc:format xml:lang="sl">številka:3</dc:format><dc:format xml:lang="sl">letnik:37</dc:format><dc:format xml:lang="sl">str. 355-366</dc:format><dc:identifier>ISSN:0025-8121</dc:identifier><dc:identifier>COBISSID:9229273</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-PI46IBZ3</dc:identifier><dc:language>sl</dc:language><dc:publisher xml:lang="sl">Medicinski razgledi</dc:publisher><dcterms:isPartOf xml:lang="sl">Medicinski razgledi</dcterms:isPartOf><dc:subject xml:lang="en">Bilirubin</dc:subject><dc:subject xml:lang="en">Etiology</dc:subject><dc:subject xml:lang="sl">hiperbilirubinemija</dc:subject><dc:subject xml:lang="en">Hyperbilirubinemia</dc:subject><dc:subject xml:lang="en">Infant, newborn</dc:subject><dc:subject xml:lang="en">Jaundice, neonatal</dc:subject><dc:subject xml:lang="en">Kernicterus</dc:subject><dc:subject xml:lang="en">Metabolism</dc:subject><dc:subject xml:lang="sl">novorojenčki</dc:subject><dc:subject xml:lang="en">Physiopathology</dc:subject><dc:subject xml:lang="en">Prevention and control</dc:subject><dc:subject xml:lang="en">therapy</dc:subject><dc:subject xml:lang="en">Toxicity</dc:subject><dc:subject xml:lang="en">Vestibular nuclei</dc:subject><dc:subject xml:lang="sl">zdravljenje</dc:subject><dc:subject xml:lang="sl">zlatenica</dc:subject><dc:subject rdf:resource="http://www.wikidata.org/entity/Q861845" /><dcterms:temporal rdf:resource="1994-2025" /><dc:title xml:lang="sl">Nekonjugirana hiperbilirubinemija pri novorojenčku| Unconjugated hyperbibirubinemia in term newborns|</dc:title><dc:description xml:lang="sl">The paper presents the metabolism of bilirubin and consequences of its toxic effect on new-born's brain. Increased production or decreased excretion of bilirubin, or a combination of both, may be the cause of neonatal jaundice. Affer passing across the blood-brain barrier, bilirubin is deposited in some regions of the brain. Unconjugated and unbound bilirubin is toxic, and is especially harmful to the brain of a new-borns. The mechanism of its toxicity is not yet understood, but it is well known that bilirubin can affect enzymes and cell membranes. The clinical picture of bilirubin encephalopathy has threephases. Late sequelae are offen manifested as cerebral palsy, deafness and mental retardation. The paper gives several recommendations for the management of severe jaundice and prevention of bilirubin encephalopathy</dc:description><dc:description xml:lang="sl">Pregledni članek povzema presnovo bilirubina in posledice toksičnega delovanjabilirubina na možgane. Povečano nastajanje bilirubina, manjše izločanje ali pa kombinacija obojega so lahko vzroki za nastanek neonatalne zlatenice. Po prehodu skozi krvno-možgansko pregrado se bilirubin kopiči v določenih delih možganov. Nekonjugirani, nevezani bilirubin je toksičen, predvsem za možgane novorojenčkov. Podrobnega mehanizma toksičnosti še ne poznamo, čeprav je ugotovljeno, da bilirubin deluje na encime in celične membrane. Klinična slika bilirubinske ence- falopatije v akutnem obdobju poteka v treh fazah. Pozne posledice se pogosto kažejo kot cerebralna paraliza, gluhost, lahko tudi kot umska manjrazvitost. Navedena so priporočilaza zdravljenje hude zlatenice in s tem za preprečevanje nastanka bilirubinske encefalopatije</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:DOC-PI46IBZ3"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:DOC-PI46IBZ3" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:DOC-PI46IBZ3/ae00425c-1792-456b-9b01-419ddf2cc51f/PDF" /><edm:rights rdf:resource="http://rightsstatements.org/vocab/InC/1.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Društvo Medicinski razgledi</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:DOC-PI46IBZ3/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:DOC-PI46IBZ3" /></ore:Aggregation></rdf:RDF>